Heidelberg Pharma AG (LON: 0QW5)
London
· Delayed Price · Currency is GBP · Price in EUR 2.570
+0.020 (0.78%)
At close: Jan 15, 2025
Heidelberg Pharma AG Cash Flow Statement
Financials in millions EUR. Fiscal year is December - November.
Millions EUR. Fiscal year is Dec - Nov.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Aug '24 Aug 31, 2024 | Nov '23 Nov 30, 2023 | Nov '22 Nov 30, 2022 | Nov '21 Nov 30, 2021 | Nov '20 Nov 30, 2020 | Nov '19 Nov 30, 2019 | 2018 - 2014 |
| Net Income | -18.77 | -20.35 | -19.7 | -26.14 | -18.37 | -10.15 | Upgrade
|
| Depreciation & Amortization | 0.82 | 0.82 | 0.68 | 0.75 | 0.72 | 0.53 | Upgrade
|
| Other Amortization | 0.05 | 0.05 | 0.08 | 0.06 | 0.01 | 0.02 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.02 | 0.07 | -0.01 | 0.01 | 0.09 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | 2.02 | -4.75 | - | - | - | - | Upgrade
|
| Loss (Gain) on Equity Investments | - | - | - | 0.01 | 0.07 | - | Upgrade
|
| Stock-Based Compensation | 1.08 | 0.96 | 0.55 | 0.69 | 0.57 | 0.7 | Upgrade
|
| Other Operating Activities | -0.57 | -0.12 | -0.33 | 0.46 | 0.01 | 0.02 | Upgrade
|
| Change in Accounts Receivable | 0.36 | 0.12 | -0.08 | 0.17 | 0.04 | -0.86 | Upgrade
|
| Change in Inventory | -3.32 | -5.9 | -3.84 | -0.52 | 0.01 | -0.06 | Upgrade
|
| Change in Accounts Payable | -1.45 | 2.12 | 2.15 | -1.91 | 1.8 | 0.61 | Upgrade
|
| Change in Unearned Revenue | -4.63 | -4.79 | 10.41 | 0.26 | -1.92 | 0.54 | Upgrade
|
| Change in Other Net Operating Assets | -5.5 | -1.91 | 1.24 | -0.45 | -0.93 | 0.09 | Upgrade
|
| Operating Cash Flow | -29.93 | -33.67 | -8.86 | -26.61 | -17.89 | -8.56 | Upgrade
|
| Capital Expenditures | -0.33 | -0.94 | -0.58 | -1.24 | -1.37 | -0.9 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.06 | 0.03 | 0.02 | - | 0.2 | - | Upgrade
|
| Sale (Purchase) of Intangibles | -0.02 | -0.02 | -0.03 | -0.15 | -0.06 | -0.06 | Upgrade
|
| Investment in Securities | - | 6.78 | - | -0.01 | -0.06 | -0.01 | Upgrade
|
| Other Investing Activities | 0 | 0 | - | - | -0 | 0 | Upgrade
|
| Investing Cash Flow | -0.29 | 5.85 | -0.6 | -1.4 | -1.29 | -0.98 | Upgrade
|
| Short-Term Debt Issued | - | - | 5 | 10 | - | - | Upgrade
|
| Total Debt Issued | - | - | 5 | 10 | - | - | Upgrade
|
| Short-Term Debt Repaid | - | -10 | - | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -0.11 | -0.09 | -0.1 | -0.09 | - | Upgrade
|
| Total Debt Repaid | -5.11 | -10.11 | -0.09 | -0.1 | -0.09 | - | Upgrade
|
| Net Debt Issued (Repaid) | -5.11 | -10.11 | 4.91 | 9.9 | -0.09 | - | Upgrade
|
| Issuance of Common Stock | - | 0.06 | 79.91 | 20.02 | 14.45 | - | Upgrade
|
| Other Financing Activities | 21.18 | -0 | -0.82 | -0.75 | -0.06 | - | Upgrade
|
| Financing Cash Flow | 16.08 | -10.05 | 84 | 29.17 | 14.29 | - | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.03 | -0.01 | 0.65 | 0 | -0.01 | -0.02 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | - | - | -0 | Upgrade
|
| Net Cash Flow | -14.11 | -37.89 | 75.19 | 1.16 | -4.9 | -9.56 | Upgrade
|
| Free Cash Flow | -30.25 | -34.61 | -9.45 | -27.85 | -19.26 | -9.46 | Upgrade
|
| Free Cash Flow Margin | -357.10% | -351.07% | -51.03% | -1369.57% | -222.24% | -126.19% | Upgrade
|
| Free Cash Flow Per Share | -0.66 | -0.74 | -0.25 | -0.86 | -0.64 | -0.34 | Upgrade
|
| Cash Interest Paid | 0.79 | 0.91 | 0.53 | 0.03 | 0.01 | - | Upgrade
|
| Levered Free Cash Flow | -23.43 | -21.5 | -7.26 | -18.84 | -12.83 | -5.99 | Upgrade
|
| Unlevered Free Cash Flow | -23.28 | -21.02 | -6.74 | -18.53 | -12.82 | -5.99 | Upgrade
|
| Change in Net Working Capital | 11.26 | 4.68 | -4 | 2.48 | 0.76 | -0.29 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.